Cargando…
Methylomic Biomarkers of Lithium Response in Bipolar Disorder: A Proof of Transferability Study
Response to lithium (Li) is highly variable in bipolar disorders (BD) and no clinical or biological predictors of long-term response have been validated to date. Using a genome-wide methylomic approach (SeqCapEpi), we previously identified seven differentially methylated regions (DMRs) that discrimi...
Autores principales: | Marie-Claire, Cynthia, Courtin, Cindie, Bellivier, Frank, Scott, Jan, Etain, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877131/ https://www.ncbi.nlm.nih.gov/pubmed/35215246 http://dx.doi.org/10.3390/ph15020133 |
Ejemplares similares
-
Methylomic biomarkers of lithium response in bipolar disorder: a clinical utility study
por: Marie-Claire, C., et al.
Publicado: (2023) -
Transcriptomics and miRNomics data integration in lymphoblastoid cells highlights the key role of immune-related functions in lithium treatment response in Bipolar disorder
por: Cattane, Nadia, et al.
Publicado: (2022) -
Can an Integrated Science Approach to Precision Medicine Research Improve Lithium Treatment in Bipolar Disorders?
por: Scott, Jan, et al.
Publicado: (2018) -
Circadian biomarkers in patients with bipolar disorder: promising putative predictors of lithium response
por: Geoffroy, Pierre Alexis, et al.
Publicado: (2014) -
A Comparison of Different Approaches to Clinical Phenotyping of Lithium Response: A Proof of Principle Study Employing Genetic Variants of Three Candidate Circadian Genes
por: Scott, Jan, et al.
Publicado: (2021)